Open Monoclonal Technology, Inc (OMT)
- Date:
- 2010-2015
- Reference:
- PBL/BIO/A/16/1
- Part of:
- Biotechnology company grey literature
- Archives and manuscripts
Collection contents
About this work
Description
Sub series contains grey literature collected from OMT in 2015, including corporate materials, patents and publications.
Publication/Creation
2010-2015
Physical description
3 digital items 19.2 MB (20155473 bytes)
Biographical note
Open Monoclonal Technology, Inc. (OMT) specialises in genetic engineering of animals for discovery of human therapeutic antibodies. It has three transgenic animal platforms: OmniRatR, OmniMouseR, and OmniFlicTM, collectively known as OmniATM. More information can be found at www.openmonoclonaltechnology.com.
Where to find it
Location Status Access Closed storesBy appointment Manual request